At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Influenza Vaccine Elicited Immune Response in Immunocompromised Patients
In Brief
An observational study evaluating Influenza vaccine for Influenza Vaccine and Immunocompromised Patients. Completed, enrolled 147 participants across 1 site.
Detailed Summary
This study aims to understand how well influenza vaccines work in some individuals with weakened immune systems compared to healthy individuals. Some people, such as those with HIV, multiple sclerosis, certain cancers, or autoimmune conditions, have more severe influenza disease courses due to their medical treatments. These individuals may also respond less effectively to vaccines. By comparing immune responses to the influenza vaccine in both immunocompromised patients and healthy participants, this study aims to identify patterns in vaccine effectiveness and side effects. The goal is to find better ways to predict vaccine response in vulnerable patients and improve protection against influenza.
Study Details
Timeline
Interventions
Standard, commercially available, quadrivalent split-vaccine against influenza is given to all study participants.